- Home
- KLIC vs MRUS Comparison
KLIC vs MRUS Comparison
Compare KLIC & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLIC
- MRUS
- Stock Information
- Founded
- KLIC 1951
- MRUS 2003
- Country
- KLIC United States
- MRUS Netherlands
- Employees
- KLIC N/A
- MRUS N/A
- Industry
- KLIC Semiconductors
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- KLIC Technology
- MRUS Health Care
- Exchange
- KLIC Nasdaq
- MRUS Nasdaq
- Market Cap
- KLIC 2.4B
- MRUS 2.8B
- IPO Year
- KLIC N/A
- MRUS 2016
- Fundamental
- Price
- KLIC $35.59
- MRUS $47.64
- Analyst Decision
- KLIC Strong Buy
- MRUS Strong Buy
- Analyst Count
- KLIC 5
- MRUS 13
- Target Price
- KLIC $52.00
- MRUS $85.00
- AVG Volume (30 Days)
- KLIC 627.5K
- MRUS 714.9K
- Earning Date
- KLIC 04-30-2025
- MRUS 05-07-2025
- Dividend Yield
- KLIC 2.31%
- MRUS N/A
- EPS Growth
- KLIC N/A
- MRUS N/A
- EPS
- KLIC 0.06
- MRUS N/A
- Revenue
- KLIC $701,167,000.00
- MRUS $36,133,000.00
- Revenue This Year
- KLIC $7.12
- MRUS $37.72
- Revenue Next Year
- KLIC $19.40
- MRUS $48.47
- P/E Ratio
- KLIC $583.14
- MRUS N/A
- Revenue Growth
- KLIC N/A
- MRUS N/A
- 52 Week Low
- KLIC $35.04
- MRUS $37.77
- 52 Week High
- KLIC $53.71
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- KLIC 30.97
- MRUS 59.86
- Support Level
- KLIC $35.04
- MRUS $45.03
- Resistance Level
- KLIC $38.18
- MRUS $47.42
- Average True Range (ATR)
- KLIC 1.44
- MRUS 2.25
- MACD
- KLIC -0.15
- MRUS 0.18
- Stochastic Oscillator
- KLIC 8.03
- MRUS 64.44
About KLIC Kulicke and Soffa Industries Inc.
Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.